(19)
(11) EP 3 806 827 A1

(12)

(43) Date of publication:
21.04.2021 Bulletin 2021/16

(21) Application number: 19819360.9

(22) Date of filing: 12.06.2019
(51) International Patent Classification (IPC): 
A61K 9/12(2006.01)
A61P 37/08(2006.01)
 A61K 47/12(2006.01)
(86) International application number:
PCT/US2019/036788
(87) International publication number:
WO 2019/241401 (19.12.2019 Gazette 2019/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 13.06.2018 US 201816007998
13.06.2018 US 201816007999
29.06.2018 US 201816023313
04.01.2019 US 201916240632
01.03.2019 US 201916290853

(71) Applicant: Hikma Pharmaceuticals USA Inc.
Eatontown, New Jersey 07724-2206 (US)

(72) Inventors:
  • POTTA, Thrimoorthy
    Chandler, AZ 85286 (US)
  • BASTIAN, Craig
    Chandler, AZ 85286 (US)
  • YAN, Ningxin
    Chandler, AZ 85286 (US)
  • GOSKONDA, Venkat
    Chandler, AZ 85286 (US)
  • CHILAMPALLI, Chandeshwari
    Chandler, AZ 85286 (US)
  • INAVOLU, Rachana
    Chandler, AZ 85286 (US)
  • NARAYANAN, Eshwaran
    Chandler, AZ 85286 (US)

(74) Representative: Elkington and Fife LLP 
Prospect House 8 Pembroke Road
Sevenoaks, Kent TN13 1XR
Sevenoaks, Kent TN13 1XR (GB)

   


(54) EPINEPHRINE SPRAY FORMULATIONS